ConductScience.org, home

Paper39200065

Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae.

Wong DW. Antibiotics (Basel), 2024. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae. Papers, record 39200065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200065

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.08, provisional
iCite
Revised in PubMed
2024-09-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wong DWDarren Whttps://orcid.org/0000-0001-6647-0302

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137,982,631In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates.Microbiol Spectr2023https://conductscience.org/library/papers/37982631PubMed
231,802,119
Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1.
Clin Infect Dis2020https://conductscience.org/library/papers/31802119PubMed
335,439,291
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Clin Infect Dis2022https://conductscience.org/library/papers/35439291PubMed
430,395,986
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Int J Antimicrob Agents2019https://conductscience.org/library/papers/30395986PubMed
538,176,458Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance.Int J Antimicrob Agents2024https://conductscience.org/library/papers/38176458PubMed
628,167,541Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28167541PubMed
726,850,824Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.Clin Microbiol Infect2016https://conductscience.org/library/papers/26850824PubMed
823,329,317Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance.J Med Microbiol2013https://conductscience.org/library/papers/23329317PubMed
935,811,669Epidemiology and Genomic Characteristics of Bloodstream Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With Decreased Susceptibility to Aztreonam/Avibactam in China.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35811669PubMed
1038,156,518Comparison of ETEST® superposition method and the MTS™ Aztreonam-avibactam strip with the reference method for aztreonam/avibactam susceptibility testing.J Antimicrob Chemother2024https://conductscience.org/library/papers/38156518PubMed
1131,722,380In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae.J Antimicrob Chemother2020https://conductscience.org/library/papers/31722380PubMed
1236,968,952Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21).JAC Antimicrob Resist2023https://conductscience.org/library/papers/36968952PubMed
1331,704,216Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.Int J Antimicrob Agents2020https://conductscience.org/library/papers/31704216PubMed
1431,828,337Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.J Antimicrob Chemother2020https://conductscience.org/library/papers/31828337PubMed
1537,154,758In Vitro Activities and Inoculum Effects of Cefiderocol and Aztreonam-Avibactam against Metallo-β-Lactamase-Producing Enterobacteriaceae.Microbiol Spectr2023https://conductscience.org/library/papers/37154758PubMed
1636,225,496A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam.Cureus2022https://conductscience.org/library/papers/36225496PubMed
1732,151,332Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.Lancet Infect Dis2020https://conductscience.org/library/papers/32151332PubMed
1828,303,449Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.Drugs2017https://conductscience.org/library/papers/28303449PubMed
1934,424,044Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34424044PubMed
2038,252,170Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/38252170PubMed

See all 56 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,670,646Achromobacter species in cystic fibrosis and chronic lung disease: a review of virulence, antibiotic resistance, diagnostic challenges, and emerging therapies.Ther Adv Respir Dis2026https://conductscience.org/library/papers/42670646PubMed
42,311,930Clinical Characteristics, Antimicrobial Resistance Profiles and Carbapenemases Genotypes of Providencia rettgeri: A 5-Year Retrospective Study in a Tertiary Teaching Hospital in Northern China.Infect Drug Resist2026https://conductscience.org/library/papers/42311930PubMed
42,192,725Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections.Antibiotics (Basel)2026https://conductscience.org/library/papers/42192725PubMed
42,191,848Aztreonam-avibactam at the frontline: A dual-agent approach to metallo-β-lactamase resistance.J Antibiot (Tokyo)2026https://conductscience.org/library/papers/42191848PubMed
41,892,432Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.Antibiotics (Basel)2026https://conductscience.org/library/papers/41892432PubMed
41,705,828
In vitro activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023.
Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41705828PubMed
41,630,025Genomic epidemiology and aztreonam-avibactam resistance mechanisms of Proteus mirabilis in china: an eight-year retrospective study.Ann Clin Microbiol Antimicrob2026https://conductscience.org/library/papers/41630025PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MBL3P50,639PubTator's text mininghttps://conductscience.org/library/genes/50639

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39200065

GET https://conductscience.org/api/papers/v1/39200065/references?page=2